EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

5.73
Delayed Data
As of Jul 02
 +0.03 / +0.53%
Today’s Change
3.78
Today|||52-Week Range
12.90
+1.06%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close5.70
Today’s open5.72
Day’s range5.65 - 5.81
Volume62,493
Average volume (3 months)179,593
Market cap$134.7M
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+76.60%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
--EcoGreen Internation...-0.01-3.85%
ADHDAlcobra Ltd+0.14+2.24%
SMMTSummit Therapeutics ...+0.40+3.78%
BLRXBioLine RX Ltd-0.15-5.66%
Data as of 07/03/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer, Treasurer &
Senior VP
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers